Smith RA, Zammit DJ, Damle NK, Usansky H, et al. ASN004, A 5T4-targeting scFv-Fc Antibody-Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models. Mol Cancer Ther 2021;20:1327-1337.
PMID: 34045226